The human gut microbiome plays a significant role in overall health, including mental well-being. However, identifying which bacteria influence diseases and understanding how they do so is still a developing area of research.
A recent study led by researchers from Harvard Medical School (HMS) sheds light on this by linking a specific gut bacterium, Morganella morganii, to major depressive disorder (MDD). This research uncovers a biological mechanism that could explain the connection and provides a foundation for future investigations.
Previous studies have shown correlations between M. morganii and depression, but it wasn’t clear whether the bacterium caused the disorder, whether depression altered the gut microbiome, or if another factor was involved.
Now, the HMS team has provided evidence suggesting that M. morganii contributes to depression through its interaction with the immune system.
The Role of Inflammation
The study, published in the Journal of the American Chemical Society, identifies how M. morganii produces a molecule in the gut that can trigger inflammation under certain conditions.
This process begins when an environmental contaminant, diethanolamine (DEA), is incorporated into a molecule made by M. morganii. DEA is a common ingredient in industrial, agricultural, and consumer products.
When DEA replaces a sugar alcohol in the bacterial molecule, the altered compound activates the immune system. This leads to the release of inflammatory proteins called cytokines, particularly interleukin-6 (IL-6).
Chronic inflammation, driven by elevated IL-6 levels, is already known to contribute to various diseases and has been linked to depression. The study proposes that this mechanism could explain how M. morganii influences brain health.
Building on Existing Evidence
The connection between M. morganii, inflammation, and depression aligns with earlier research. IL-6 has been repeatedly associated with MDD, and M. morganii has been linked to inflammatory conditions like type 2 diabetes and inflammatory bowel disease (IBD).
Together, these findings strengthen the case that M. morganii might play a role in some cases of depression.
While the study suggests that M. morganii contributes to MDD through chronic inflammation, further research is needed to confirm this link. Future studies will aim to determine how significant this mechanism is and what proportion of depression cases it might influence.
Implications for Diagnosis and Treatment
The discovery that DEA can become part of a molecule that triggers inflammation highlights a potential new biomarker for depression. By identifying this altered molecule in the body, doctors could diagnose certain types of depression more effectively.
Additionally, this finding supports the idea that some cases of depression may have an inflammatory or autoimmune component, opening the door to new treatments.
Drugs that modulate the immune system, for example, could offer relief for patients whose depression is linked to chronic inflammation. These treatments might target the inflammation triggered by M. morganii or similar bacteria in the gut microbiome.
A Broader Perspective on Gut Bacteria and Health
This research also has broader implications. It demonstrates how bacterial products can alter human biology by incorporating environmental contaminants. The researchers believe this finding could inspire new studies exploring other ways gut bacteria interact with the immune system and affect health.
The study is part of ongoing collaborations between labs at HMS that focus on understanding the microbiome’s impact on health.
These collaborations have already made significant discoveries, such as identifying specific bacterial molecules that influence inflammation, autoimmune diseases, and even responses to cancer immunotherapy.
A Step Toward Better Understanding
This study provides a detailed example of how a single bacterial species, M. morganii, may contribute to depression through inflammation. It highlights the complex interplay between gut bacteria, environmental factors, and human health.
While more research is needed to confirm these findings and explore their implications, this work represents a significant step toward understanding the microbiome’s role in mental health and developing new tools for diagnosis and treatment.
If you care about health, please read studies that scientists find a core feature of depression and this metal in the brain strongly linked to depression.
For more information about health, please see recent studies about drug for mental health that may harm the brain, and results showing this therapy more effective than ketamine in treating severe depression.
The research findings can be found in the Journal of the American Chemical Society.
Copyright © 2025 Knowridge Science Report. All rights reserved.
